Tatva Chintan Pharma Chem Limited
NSE: TATVAMarket Closed • NSE
Day range
52 week range
Tatva Chintan Pharma Chem Limited closed at INR1804.80 (-2.74%) on volume 0.86x its 20-day average, trading 10.15% below its 52-week high.
2026-Q1
Q1 FY2026 Financial Results
PAT moved -31.9% QoQ
2026-09-11
DIVIDEND Announced
Dividend - Rs 2 Per Share
2025-09-12
DIVIDEND Announced
Dividend - Re 1 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Low Debt Profile: Debt-to-Equity is comfortable at 0.15x
High Cash Flow Conversion: CFO/PAT averaged 1.98x over last 3 years
Risks
Stretched Valuation: Trading at a high P/E multiple of 82.1x
Bull case
Market Leadership: Established operational scale in Specialty Chemicals.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 11 Sept 2026 | Dividend | ₹2.00 / share | — | 11 Sept 2026 |
| 12 Sept 2025 | Dividend | ₹1.00 / share | — | 12 Sept 2025 |
| — | Annual General Meeting | Annual General Meeting | — | 06 Sept 2024 |
| 06 Sept 2024 | Dividend | ₹2.00 / share | — | 06 Sept 2024 |
| 08 Sept 2023 | Dividend | ₹2.00 / share | — | 08 Sept 2023 |
| — | Annual General Meeting | Annual General Meeting | — | 08 Sept 2023 |
| 09 Sept 2022 | Dividend | ₹2.00 / share | — | 08 Sept 2022 |
| — | Annual General Meeting | Annual General Meeting | — | 08 Sept 2022 |
| — | Annual General Meeting | Annual General Meeting | — | 17 Sept 2021 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 UltraTech Cement LimitedULTRACEMCO Open analysis | ₹3.14L | 36.80 | 2.30% | ₹25,799.47 | ₹2,982.76 | +11.86% | +20.17% |
 JSW Steel LimitedJSWSTEEL Open analysis | ₹2.85L | 11.52 | 0.60% | ₹47,364.00 | ₹4,651.00 | +11.55% | +112.96% |
 Hindustan Zinc LimitedHINDZINC Open analysis | ₹2.30L | 13.46 | 2.07% | ₹13,687.00 | ₹5,425.00 | +77.22% | +146.14% |
 Asian Paints LimitedASIANPAINT Open analysis | ₹2.24L | 47.08 | 1.19% | ₹10,541.94 | ₹1,539.25 | +17.94% | +39.96% |
 Tata Steel LimitedTATASTEEL Open analysis | ₹2.17L | 19.64 | 2.33% | ₹60,794.00 | ₹2,385.00 | +14.32% | +18.83% |
 Hindalco Industries LimitedHINDALCO Open analysis | ₹2.00L | 12.21 | 0.56% | ₹84,825.00 | ₹7,013.00 | +32.06% | +75.15% |
 Grasim Industries LimitedGRASIM Open analysis | ₹1.96L | 34.47 | 0.35% | ₹11,794.71 | ₹246.65 | -70.60% | -82.61% |
 Solar Industries India LimitedSOLARINDS Open analysis | ₹1.81L | 90.88 | 0.06% | ₹3,668.00 | ₹666.00 | +70.29% | +88.67% |
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
IndiaBasic Materials
Is Tatva Chintan Pharma Chem Limited Shariah compliant?
Tatva Chintan Pharma Chem Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (2.85%) complies with AAOIFI threshold (≤ 33%).
What is Tatva Chintan Pharma Chem Limited's current valuation relative to peers?
Tatva Chintan Pharma Chem Limited trades at a P/E of 82.1x compared to the sector median of 21.4x, and a Price-to-Book of 5.4x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.15x. Interest coverage is 19.8x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.